Investors

Corporate Report

FY2022

Full Report (9.1 MB)
ONO’s Mission (550 KB)
Contents, Editorial Policy, External ESG Assessment (807 KB)
Advances in Challenges Taken On (363 KB)
Business and Features (109 KB)
Financial ＆ Non-Financial Highlights (68 KB)
Top Message (926 KB)
ONO’s Value Creation Process (532 KB)
Sustainable Management Policy (181 KB)
Growth Strategy (89 KB)
Redefinition of Material Issues (100 KB)
Creation of Innovative Drugs (139 KB)
Pipeline Expansion (200 KB)
Maximization of Product Value (47 KB)
Realization of Direct Sales in the US and Europe (538 KB)
Expansion of Business Domains (100 KB)
Corporate Transformation through Digital ＆ IT (72 KB)
Strengthening of Financial Capital (57 KB)
Expansion of Human Capital (233 KB)
Intellectual Property Strategies (44 KB)
Open Innovation (259 KB)
Promotion of Diverse Partnerships (113 KB)
Assurance of Product Reliability and Safety (100 KB)
Stable Supply of Products (100 KB)
Protection of Environment (279 KB)
Respect for Human Rights (278 KB)
Thorough Compliance (80 KB)
Supply Chain Management (43 KB)
Social Contribution Activities (422 KB)
Round-table Discussion with the Outside Directors (1.2 MB)
Management (372 KB)
Corporate Governance (105 KB)
Risk Management (142 KB)
Financial Review (93 KB)
Consolidated Financial Summary (36 KB)
Details of Revenue (36 KB)
Consolidated Financial Statement (101 KB)
Corporate Information / Stock Information (42 KB)